Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones01-16

DJ Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.82% to $703.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.83% to 5,949.91 and the Dow Jones Industrial Average rising 1.65% to 43,221.55.

Regeneron Pharmaceuticals Inc. closed 41.92% below its 52-week high of $1,211.20, which the company reached on August 27th.

The stock outperformed some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 0.69% to $268.94, Moderna Inc. $(MRNA)$ rose 0.90% to $34.77, and Gilead Sciences Inc. $(GILD)$ rose 1.52% to $92.38.

Trading volume (758,976) remained 118,310 below its 50-day average volume of 877,286.

Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 15, 2025 17:20 ET (22:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2503960372?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-16 06:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503960372","market":"other","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> rallied 1.82% to $703.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 1.83% to 5,949.91 and the Dow Jones Industrial Average  rising 1.65% to 43,221.55. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 41.92% below its 52-week high of $1,211.20, which the company reached on August 27th. \n</p>\n<p>\n     The stock outperformed some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 0.69% to $268.94, Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> rose 0.90% to $34.77, and Gilead Sciences Inc. <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a> rose 1.52% to $92.38. \n</p>\n<p>\n     Trading volume (758,976) remained 118,310 below its 50-day average volume of 877,286. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 15, 2025 17:20 ET (22:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-16 06:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2503960372","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503960372","pubTimestamp":1736979600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rallied 1.82% to $703.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.83% to 5,949.91 and the Dow Jones Industrial Average  rising 1.65% to 43,221.55.Regeneron Pharmaceuticals Inc. closed 41.92% below its 52-week high of $1,211.20, which the company reached on August 27th.The stock outperformed some of its competitors Wednesday, as Amgen Inc.  rose 0.69% to $268.94, Moderna Inc.  rose 0.90% to $34.77, and Gilead Sciences Inc.  rose 1.52% to $92.38.Trading volume  remained 118,310 below its 50-day average volume of 877,286.Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"再生元制药股价周三上涨，但仍跑输大盘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 1.82% to $703.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.83% to 5,949.91 and the Dow Jones Industrial Average  rising 1.65% to 43,221.55. \n\n\n     Regeneron Pharmaceuticals Inc. closed 41.92% below its 52-week high of $1,211.20, which the company reached on August 27th. \n\n\n     The stock outperformed some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 0.69% to $268.94, Moderna Inc. $(MRNA)$ rose 0.90% to $34.77, and Gilead Sciences Inc. $(GILD)$ rose 1.52% to $92.38. \n\n\n     Trading volume (758,976) remained 118,310 below its 50-day average volume of 877,286. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 15, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 15, 2025 17:20 ET (22:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2503960372"}